IXC 0.00% 6.0¢ invex therapeutics ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7

  1. 119 Posts.
    lightbulb Created with Sketch. 27
    Yes, there seems to be a connotation of leaning away from PMD. In which case, EMA trial initially. ICP reduction is the key to presendin and the the other pressure indications which are larger in market scale. Sure, we need approval for IIH though this is the orphan vehicle to markets we should be more interested in.
    IMO.
    Last edited by Easy Street: 20/10/21
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
0.000(0.00%)
Mkt cap ! $4.509M
Open High Low Value Volume
6.0¢ 6.0¢ 6.0¢ $27 445

Buyers (Bids)

No. Vol. Price($)
1 155 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 15689 1
View Market Depth
Last trade - 10.20am 01/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.